Latest filing published 20 Nov 2017 for X4 Pharmaceuticals, Inc.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -92.3%Entry US$2,773.80 · Close at T+365 US$214.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
NeoMed Innovation V L.P.: trading record in brief
NeoMed Innovation V L.P. appears in our data through filings on X4 Pharmaceuticals, Inc shares, published by SEC (Form 4). Activity is concentrated on a single trading day, 20 November 2017, with 4 filings.
Every open-market trade on record is a purchase: 1 purchase worth €2.6M, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Most recently, on 20 November 2017, the filings show a transaction in X4 Pharmaceuticals, Inc. The last purchase on record was published on 20 November 2017, which is 3,276 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to NeoMed Innovation V L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 246,682 sharesCommon StockSEC:0000899243-17-027028:0
- 41,878 sharesCommon StockSEC:0000899243-17-027028:1
- 279,079 sharesCommon StockSEC:0000899243-17-027028:2
- 300,000 shares@ US$10.00100.0% of flowCommon StockSEC:0000899243-17-027028:3Canonical exit: 18 Feb 2018 (T+90)
4 of 4 declarations
